Published • loading... • Updated
Enrollment complete in trial of experimental Parkinson's treatment
Summary by Parkinson's News Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Enrollment complete in trial of experimental Parkinson's treatment
Vertero Therapeutics has completed patient enrollment in a Phase 1b clinical trial testing VT-5006, an experimental treatment designed to target gut-related mechanisms believed to contribute to Parkinson’s disease. The Phase 1b study (NCT07310264) includes 24 adults with early- or moderate-stage Parkinson’s. It will assess the treatment’s safety and how it moves into, through, and out of […] The post Enrollment complete in trial of experimental …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
